Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
Damage to the optic nerve and the death of associated retinal ganglion cells (RGCs) by elevated intraocular pressure (IOP), also known as glaucoma, is responsible for visual impairment and blindness in millions of people worldwide. The ocular hypertension (OHT) and the deleterious mechanical forces...
Main Author: | Najam A. Sharif |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.729249/full |
Similar Items
-
Neuroprotection in glaucoma
by: Vasudevan Sushil, et al.
Published: (2011-12-01) -
Role of interleukin-6 in the pathogenesis of glaucoma
by: Pan Liu, et al.
Published: (2018-10-01) -
Aqueous Flare Changes in Ex-PRESS Glaucoma Shunt Eyes After 4.7 Tesla High-Field Magnetic Resonance Imaging
by: Edo, A., et al.
Published: (2023) -
Characteristic Cytokine Profiles of Aqueous Humor in Glaucoma Secondary to Sturge-Weber Syndrome
by: Cheng Peng, et al.
Published: (2020-01-01) -
Surgical natural uveoscleral outflow activation in the primary and secondary glaucoma patients treatment
by: N. G. Zavgorodnaya, et al.
Published: (2014-04-01)